Table Of Content

SUBJECT AND DRUG INDEXES TO ADVERSE DRUG REACTION BULLETIN Nos 218—223 February 2003 — December 2003 SUBJECT INDEX abdominal pain, 839, 848, 853 dental caries, 852 acne, 848 dermatitis, 853, 856 adenocarcinoma diabetes mellitus, 837, 841, 852 colon, 849 diarrhoea, 840, 848, 851, 852, 853, 857 adverse drug reactions in athletes, 847-850 diplopia, 840 adverse effects of pharmaceutical discontinuation reactions, 839-840 excipients, 851-854 dizziness, 840, 857 adverse reactions to and safety of newer disease- drug-induced cardiac failure, 843-846 modifying antirheumatic drugs for rheumatoid dry mouth, 839, 840, 841 arthritis, 855-858 dyspnoea, 843, 855 adverse reactions to drugs used in dystonia, 840 mental health, 839-842 eczema, 853 aggression, 848 endophthalmitis agranulocytosis, 841 Candida, 849 akathisia, 840 eosinophilia, 853 akinesia, 840 erythema multiforme, 853 alopecia, 840, 857 extrapyramidal symptoms, 840 anaemia, 848, 855, 857 fatigue 843, 847, 848, 855 anaphylaxis, 853, 855 flatulence, 853 angioedema, 853 galactorrhoea, 841 anorgasmia, 839 gastric rupture, 848 anxiety, 839, 840 gastrointestinal aplastic anaemia, 840 disturbance, 840 arrhythmia, 839, 845 haemorrhage, 839 aspergillosis, 856 obstruction, 841 asthma, 853 granulomatous panniculitis, 853 ataxia, 840 gynaecomastia, 841, 848 atrial fibrillation, 853 headache, 839, 840, 852, 855, 857 avascular necrosis heart failure, 843-845, 856 femur, 848 hepatitis bone marrow suppression, 836 peliosis, 849 breast size, hepatoma, 849 reduction, 848 hepatotoxicity, 840, 856, 857 cachexia, 855 hirsutism, 848 cardiac failure, 843, 845 hypercholesterolaemia, 837 cardiomyopathy, 841, 844, 845 hyperglycaemia, 841, 848 cerebral haemorrhage, 848 hyperkalaemia, 843, 847 cheilitis, 853 hyperkinesis, 853 coccidiomycosis, 856 hyperlipidaemia, 835, 837, 849 cognitive impairment, 841 hyperostosis, 848 confusion, 840 hyperprolactinaemia, 839, 841 constipation, 839, 840, 841 hypersalivation, 841 coronary artery disease, 835, 837 hypersensitivity, 852, 853 creatinine kinase hypertension, 840, 843, 844, 847-849, 857 raised, 840 hyperthermia, 840, 848, 849 Davies, David Margerison hypertonia, 852 obituary, 842 hypoglycaemia, 851 cxlv hypogonadotrophic hypogonadism, 848 polyuria, 840 hyponatraemia, 839, 840 priapism, 840, 849 hypotension, 840, 841, 844, 847, 855 prostate postural, 839, 841 cancer, 849 hypothyroidism, 840 enlargement, 849 impotence, 839 malignancy, 849 infection, 857 pruritus, 853, 855, 857 Candida, 856 psychosis, 848 Cryptococcus neoformans, 856 pulmonary Histoplasma capsulatum, 856 embolus, 847 Listeria monocytogenes, 856 oedema, 844 Nocardia, 856 QT prolongation, 841 Pneumocystis Jirovect, 856 rash, 840, 841, 857 insomnia, 839, 840, 852, 853 papular, 853 insulin resistance, 835, 836, 837 red-cell aplasia, 849 jaundice, 848 rhabdomyolysis, 848 cholestatic, 841] rhinitis, 853 joint pain, 855 rigors, 855 kernicterus, 853 schizophrenia, 841, 845, 848 lactic acidosis, 836 sedation, 839, 840, 841 Launois—Bensaude syndrome, 835 seizures, 840, 841, 856 left ventricular dysfunction, 844-845 septicaemia, 856 leucopenia, 841 sinusitis, 856 libido skin decreased, 839 irritation, 851 lipoatrophy, 835-837 squamous cell carcinoma, 856 lipodystrophy associated with treatment of HIV-1 Stevens—Johnson syndrome, 840 infection, 835-838 strabisimus, 852 lipodystrophy syndrome, 835-836 striae, 848 lipomatosis, 835 stroke, 848 lymphoma, 856 sweating, 839, 840 Madelung’s syndrome, 835 syncope, 853 melanoma, 856 systemic lupus erythematosus, 856 meningitis, 856 tachyarrhythmia, 845 aseptic, 856 tachycardia, 844, 847, 853 metabolic ‘syndrome X°, 835 tardive dyskinesia, 840, 841 muscle cramps, 848 tendon rupture, 848 myocarditis, 841, 845 myopathy, 836 teratogenesis, 840, 852 thrombocytopenia, 840 naevi, 848 nausea, 839, 840, 853, 855, 857 torsade de pointes, 841 nervousness, 839 tremor, 840 neuroleptic malignant syndrome, 840, 841 tuberculosis, 856—857 neuropathy, 836 tumour necrosis factor, 855 neutropenia, 841, 857 urinary oedema, 840, 843, 844, 847, 848 hesitancy, 840 oesophageal reflux, 848 retention, 839, 841 oligomenorrhoea, 848 urticaria, 853, 855 opisthotonus, 852 vasculitis, 853, 856 optic neuritis, 856 vision blurred, 839 pancreatitis, 836, 840 vomiting, 839, 853 pancytopenia, 857 weight gain, 839, 840, 841 paraesthesia, 840 weight loss, 840, 855, 857 photosensitivity reactions, 841 wheezing, 853 pneumonia, 857 Wilms’s tumour, 849 cx\vi DRUG INDEX A capital initial letter indicates a proprietary name, chemical name, or abbreviation. The symbol ‘®) also indicates a proprietary preparation 3-adrenoceptor antagonists, 844 E102. See tartrazine abacavir, 836, 837 E104. See quinoline yellow acacia, 852 E110. See sunset yellow adalimumab, 855, 856 E127. See erythrosine aluminum magnesium silicate, 852 E133. See brilliant blue amiodarone, 845 E200. See sorbic acid amisulpride, 841 E414. See acacia amitriptyline, 839 E420. See sorbitol amlodipine, 844 E421. See mannitol anabolic steroids, 847-849 E445. See glycerol anakinra, 855, 857 E558. See bentonite androstenedione, 849 E901. See beeswax anthracyclines, 845 E951. See aspartame Arava" , 855 E952. See cyclamate aspartame, 852, 853 E954. See saccharin astemizole, 845 E967. See xylitol atazanavir, 837 Enbrel“, 855 beeswax, 852 ephedrine, 840, 847, 848 bentonite, 852 epirubicin, 845 benzalkonium chloride, 852 erythromycin, 845 benzyl alcohol, 853 erythropoietin, 847, 849 bicarbonate, 848, 852 erythrosine, 852, 853 brilliant blue, 852 ethanol, 844, 851, 852 caffeine, 847, 848 ethchlorvynol, 842 carbamazepine, 840 fast green, 852 carbenoxolone, 844 flecanide, 845 carbon dioxide, 852 fludrocortisone, 844 carboplatin, 845 fluorescein, 852, 853 cellulose acetate phthalate, 852 fluorouracil, 845 cetrimonium bromide, 852 fluoxetine, 839 chlorpromazine, 841 fructose, 852 chlortalidone, 844 furosemide, 842 citric acid, 852 gamma-hydroxybutyrate, 848 clenbuterol, 847, 848 elatin, 851, 852, 853 clozapine, 841, 845 sluten, 852 g9ag cortisone, 844 its lycerol, 851, 852 Crixivan “, 835 glycol, 851 cyclamate, 852, 853 glycyrrhizic acid, 844 cyclophosphamide, 845 Herceptin“, 845 dextrose, 852 hydrocortisone, 844 dichloralphenazone, 842 ifosfamide, 845 didanosine, 836 indinavir, 835, 836 digoxin, 845 infliximab, 855-858 diltiazem, 844, 848 insulin, $36, 848 doxazosin, 844 interferon drug interaction a, 844, 845 aspirin/SSRIs, 839 3, 845 leflunomide/methotrexate, 857 y, 845 isocarboxazid, 840 recombinant interleukin 2, 845 Kineret “, 855 Remicade", 855 lactose, 852, 853 risperidone, 841 lamivudine, 836 ritonavir, 837 lanolin, 852 rosiglitazone, 844 leflunomide, 855, oO J\ — saccharin, 852, 853 lidocaine, 845 shellac, 852 lithium, 840, 848 sodium lauryl sulfate, 852 mannitol, 852 sorbic acid, 852 menthol, 853 sorbitol, 851, 852, 853 methotrexate, 855, 856, 857 sotalol, 845 mirtazapine, 840 spironolactone, 847 moclobemide, 840 stanozolol, 848 nevirapine, 837 stavudine, 836, 837 nifedipine, 844 sucrose, 851-853 nitrogen, 852 sunset yellow, 852, 853 non-steroidal anti-inflammatory drugs, 843, 844, 847, tartrazine, 852, 853 848 tenofovir, 836, 837 norfloxacin, 848 terfenadine, 845 Norvir", 851 thimerosal. See thiomersal NSAIDs. See non-steroidal anti-inflammatory drugs thiomersal, 852, 853 olanzapine, 841 thioridazine, 841, 845 paclitaxel, 845 timolol, 847 parabens, 852 tranylcypromine, 840 paroxetine, 839 trastuzumab, 845 peppermint oil, 853 phenelzine, 840 trazodone, 840 phloxine B, 852 tricyclic antidepressants, 839 pioglitazone, 844 troglitazone, 844 polyethylene glycol, 843 valproate, 840 polyvinyl acetate phthalate, 852 Vaselin“e , 852 prednisolone, 844 venlafaxine, 840 procainamide, 842, 845 verapamil, 844 propofol, 845 vitamin A, 848 pseudoephedrine, 847, 848 warfarin, 842 quetiapine, 841 water, 851 quinidine, 839, 841, 845 xylitol, 852 quinoline yellow, 852 zalcitabine, 836 reboxetine, 840 zidovudine, 836 cx\viii oe